Skip to main content
Premium Trial:

Request an Annual Quote

Mobious Genomics Wins European Patent for Gene-Sequencing Technology

NEW YORK, Sept. 10 - Mobious Genomics today said it has received a patent from the European patent office for its ultra high-throughput sequencing technology.


Called "polynucleotide sequence analysis," the patent, based on direct, linear DNA analysis, covers "real-time monitoring of cellular replication processes" for ultra high-thoughput genomic analysis, the company said.


Daniel Densham, CEO of US-based Mobious, said the company is "already in discussions" with international pharma companies to provide sequencing services based on its technology, called Molecular Resonance Sequencing.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.